The first Bio-Path Holdings trade was made in Q1 2019.
Since then Jim Simons bought shares nine more times and sold shares on seven occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Bio-Path Holdings anymore.
Avg closing price
Price range
Sold -23.3 Thousand shares
Q4 2023
Avg closing price
$0.53
Price range
$0.36
-
$0.75
Increased shares by 8.9% (+1.9 Thousand shares)
Q3 2023
Avg closing price
$0.69
Price range
$0.36
-
$1.78
Increased shares by 5.4% (+1.1 Thousand shares)
Q2 2023
Avg closing price
$1.54
Price range
$1.22
-
$2.13
Increased shares by 5.7% (+1.1 Thousand shares)
Q1 2023
Avg closing price
$1.80
Price range
$1.39
-
$2.26
Increased shares by 3.2% (+600 shares)
Q4 2022
Avg closing price
$2.19
Price range
$1.32
-
$3.46
Increased shares by 3.3% (+600 shares)
Q3 2022
Avg closing price
$3.80
Price range
$3.03
-
$4.43
New holding (+18 Thousand shares)
Q2 2022
Avg closing price
$3.38
Price range
$2.83
-
$4.02
Sold -73.8 Thousand shares
Q2 2021
Avg closing price
$6.16
Price range
$5.13
-
$7.63
Sold 4.9% shares (-3.79 Thousand shares)
Q1 2021
Avg closing price
$5.93
Price range
$3.63
-
$11.77
Increased shares by 27.0% (+16.5 Thousand shares)
Q4 2020
Avg closing price
$3.75
Price range
$3.21
-
$5.26
Increased shares by 37.3% (+16.6 Thousand shares)
Q3 2020